Global Stem Cell Treatments for Cancer Market 2022-2028

The global stem cell treatments for cancer market stood at around USD 2,074 million in 2021 and is projected to rise to a worth of USD 4,529 million by 2028.

Cancer stem cells (CSCs) are responsible for carcinogenesis and tumorigenesis and are involved in drug and radiation resistance, metastasis, tumor relapse and initiation. According to market research study published by Publisher, the global stem cell treatments for cancer market stood at around USD 2,074 million in 2021 and is projected to rise to a worth of USD 4,529 million by 2028 end, thereby garnering a CAGR of 11.8% during 2022-2028. The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global stem cell treatments for cancer market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the stem cell treatments for cancer industry.

What's Inside a Bonafide Research`s industry report?

Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globally

Download Sample

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the cancer type, and region. The global market for stem cell treatments for cancer can be segmented by cancer type: bone cancer, brain cancer, breast cancer, colorectal cancer, leukemia, lung cancer, melanoma, others. In 2021, the breast cancer segment made up the largest share of revenue generated by the stem cell treatments for cancer market. Stem cell treatments for cancer market is further segmented by region: Asia Pacific, Europe, North America, Rest of the World (RoW). North America was the largest contributor to the global stem cell treatments for cancer market in 2021. By cancer type: - bone cancer - brain cancer - breast cancer - colorectal cancer - leukemia - lung cancer - melanoma - others By region: - Asia Pacific - Europe - North America - Rest of the World (RoW)

Make this report your own

Have queries/questions regarding a report?

Take advantage of intelligence tailored to your business objective

Arun Kalwani

Arun Kalwani

Research Analyst

The report explores the recent developments and profiles of key vendors in the Global Stem Cell Treatments for Cancer Market, including apceth Biopharma GmbH, Benitec Biopharma Ltd., BioNTech SE, Caladrius Biosciences, Inc., Celgene Corporation, ExCellThera Inc., Fluxion Biosciences, Inc., Gamida-Cell Ltd, Genexine, Inc., ImmunoCellular Therapeutics, Ltd., OncoCyte Corporation, OncoMed Pharmaceuticals, Inc., Pluristem Therapeutics Inc., SELLAS Life Sciences Group, Inc., Sphere Fluidics Limited, ViaCyte, Inc., among others. *REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES Historical & Forecast Period This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year. Scope of the Report - To analyze and forecast the market size of the global stem cell treatments for cancer market. - To classify and forecast the global stem cell treatments for cancer market based on cancer type, region. - To identify drivers and challenges for the global stem cell treatments for cancer market. - To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global stem cell treatments for cancer market. - To identify and analyze the profile of leading players operating in the global stem cell treatments for cancer market.

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now
Arun Kalwani

Why Choose This Report - Gain a reliable outlook of the global stem cell treatments for cancer market forecasts from 2022 to 2028 across scenarios. - Identify growth segments for investment. - Stay ahead of competitors through company profiles and market data. - The market estimate for ease of analysis across scenarios in Excel format. - Strategy consulting and research support for three months. - Print authentication provided for the single-user license.

Table of Contents

  • TABLE OF CONTENTS
  • FIGURES AND TABLES
  • PART 1. INTRODUCTION
  • · Report description
  • · Objectives of the study
  • · Market segment
  • · Years considered for the report
  • · Currency
  • · Key target audience
  • PART 2. METHODOLOGY
  • PART 3. EXECUTIVE SUMMARY
  • PART 4. MARKET OVERVIEW
  • · Introduction
  • · Drivers
  • · Restraints
  • · Impact of COVID-19 pandemic
  • PART 5. MARKET BREAKDOWN BY CANCER TYPE
  • · Bone cancer
  • · Brain cancer
  • · Breast cancer
  • · Colorectal cancer
  • · Leukemia
  • · Lung cancer
  • · Melanoma
  • · Others
  • PART 6. MARKET BREAKDOWN BY REGION
  • · Asia Pacific
  • · Europe
  • · North America
  • · Rest of the World (RoW)
  • PART 7. KEY COMPANIES
  • · apceth Biopharma GmbH
  • · Benitec Biopharma Ltd.
  • · BioNTech SE
  • · Caladrius Biosciences, Inc.
  • · Celgene Corporation
  • · ExCellThera Inc.
  • · Fluxion Biosciences, Inc.
  • · Gamida-Cell Ltd
  • · Genexine, Inc.
  • · ImmunoCellular Therapeutics, Ltd.
  • · OncoCyte Corporation
  • · OncoMed Pharmaceuticals, Inc.
  • · Pluristem Therapeutics Inc.
  • · SELLAS Life Sciences Group, Inc.
  • · Sphere Fluidics Limited
  • · ViaCyte, Inc.
  • *REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
  • DISCLAIMER

Why Bonafide Research?

  • Our seasoned industry experts bring diverse sector experience, tailoring methodologies to your unique challenges.
  • Leveraging advanced technology and time-tested methods ensures accurate and forward-thinking insights.
  • Operating globally with a local touch, our research spans borders for a comprehensive view of international markets.
  • Timely and actionable insights empower swift, informed decision-making in dynamic market landscapes.
  • We foster strong client relationships based on trust, transparency, and collaboration.
  • Our dedicated team adapts and evolves strategies to meet your evolving needs.
  • Upholding the highest standards of ethics and data security, we ensure confidentiality and integrity throughout the research process.

How client has rates us?

Requirement Gathering & Methodology
92%
Data Collection Techniques
97%
Our Research Team & Data Sourcing
93%
Data Science & Analytical Tools
81%
Data Visualization & Presentation Skills
86%
Project/ Report Delivery & After Sales Services
88%
Logo

Global Stem Cell Treatments for Cancer Market 2022-2028

Contact usWe are friendly and approachable, give us a call.